# Effect of a Combination of Lactase and L. Salivarius DSM 34078 in Individuals With Lactose Intolerance

> **NCT06107088** · NA · COMPLETED · sponsor: **Novozymes A/S** · enrollment: 76 (actual)

## Conditions studied

- Lactose Intolerance

## Interventions

- **DIETARY_SUPPLEMENT:** Active 1
- **DIETARY_SUPPLEMENT:** Active 2
- **DIETARY_SUPPLEMENT:** Active 3
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06107088
- **Lead sponsor:** Novozymes A/S
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-20
- **Primary completion:** 2024-07-10
- **Final completion:** 2024-07-10
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2024-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06107088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06107088, "Effect of a Combination of Lactase and L. Salivarius DSM 34078 in Individuals With Lactose Intolerance". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06107088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
